Monitoring of fibrinolytic treatment with chromogenic substrate assays.
D002863:Chromogenic Compounds; D005342:Fibrinolysis; D010960:Plasminogen Activators / Q000627:therapeutic use; D013300:Streptokinase / Q000627:therapeutic use; D013927:Thrombosis / Q000188:drug therapy*; D014568:Urokinase-Type Plasminogen Activator / Q000627:therapeutic use
D002863:Chromogenic Compounds; D013300:Streptokinase; D010960:Plasminogen Activators; D014568:Urokinase-Type Plasminogen Activator